Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 834

Emailed: 0

PDF Downloaded: 206

International Journal of Pharmaceutical Chemistry and Analysis


Development and validation of stability indicating assay method for the estimation of lafutidine and domperidone in capsule dosage form


Full Text PDF Share on Facebook Share on Twitter


Author Details : CK Gadewar, SJ Wadher, SS Pekamwar, SG Gattani

Volume : 3, Issue : 4, Year : 2016

Article Page : 219-228


Suggest article by email

Abstract

A simple, sensitive, precise and specific high performance liquid chromatography method was developed and validated for the determination of Lafutidine and Domperidone in Lafutidine and Domperidone sustained release capsule. The separation was carried out by using a mobile phase consisting Acetonitrile: pH 6.5 phosphate buffer in ratio of 30:70. The column used was Xterra 250mm X 4.6mm, 5µ with flow rate 1 ml/min using UV detection at 276 nm. The retention time of Lafutidine and Domperidone were found to be 7.0 and 15.5 min respectively.  Degradation study of Lafutidine and Domperidone in its capsule form was conducted under condition of hydrolysis, oxidation, thermal and photolysis, the results of analysis were validated statistically and by recovery studies (mean recovery = 99.94). The result of study showed that the proposed method is simple, rapid, precise and accurate, which is useful for the routine determination of Lafutidine and Domperidone in pharmaceutical dosage form.

Keywords:
Lafutidine, Domperidone, Method development, Validation, Forced degradation

How to cite : Gadewar C, Wadher S, Pekamwar S, Gattani S, Development and validation of stability indicating assay method for the estimation of lafutidine and domperidone in capsule dosage form. Int J Pharm Chem Anal 2016;3(4):219-228

Copyright © 2016 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)